Want to Join Our Team?
Learn about Blue Matter's innovative work experiences, enriching development opportunities, team-oriented "People First" culture, and a lot more.
Insights
Access our ever-expanding library of thought leadership resources for strategic leaders and professionals in biopharma. It’s full of useful content addressing industry challenges, best practices, therapeutic markets, innovative ideas, and forward-looking insights.
Featured eBook
The “Best Practice Organization” and Its Importance for Success in Today’s Biopharma Industry
Learn More >
Blog
Expanding a Biotech Business into Europe: Determining Which Model to Use When Launching Your First Product and Building Country Operations in Europe
Blog
How will the change to a more narrow FDA label for Aduhelm (aducanumab) help Biogen?
Blog
Keeping Biopharma Up At Night: How the Chronic Insomnia Market Raises Big Questions About Digital Therapeutics
Whitepaper
Summary of Blue Matter Breakfast Club #9: Is Patient Centricity Always Critical?
Whitepaper
Beyond Linear Drug Development: Leveraging the Constellation Approach in Rare Diseases
Whitepaper
Alzheimer’s Disease: An In-Depth Look at a Formidable Foe
Blog
What challenges could Biogen’s Aduhelm (aducanumab) face as it goes to market?
eBook
Digital Therapeutics 101: An Introduction & Overview
Blog
What impact is Biogen’s Aduhelm (aducanumab) likely to have on the Alzheimer’s Market?
Blog
Upcoming Webinar: Psychedelics in CNS Therapeutics
Whitepaper
An Overview of Cross-Border Collaborations on HTA, Pricing Negotiation, & Procurement
Blog
Alzheimer’s Disease: An In-Depth Look at a Formidable Foe
Blog
Beyond Linear Drug Development: Leveraging the Constellation Approach in Rare Diseases
Blog
An Overview of Cross-Border Collaborations on Healthcare Technology Assessment, Pricing Negotiation, and Procurement
Whitepaper
Summary of Blue Matter Breakfast Club #8: How can a company focused on rare diseases optimize its customer-facing teams?
Blog
Recap: Psychedelic Therapeutics and Drug Development Conference
